The DOI matches its Crossref record; 466 of the 466 references it cites were found in a registry or an index.
Antimicrobial Resistance in ESKAPE Pathogens
Open accessAbstract
Antimicrobial-resistant ESKAPE ( E nterococcus faecium , S taphylococcus aureus , K lebsiella pneumoniae , A cinetobacter baumannii , P seudomonas aeruginosa , and E nterobacter species) pathogens represent a global threat to human health. The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options for serious infections, increased the burden of disease, and increased death rates due to treatment failure and requires a coordinated global response for antimicrobial resistance surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is currently included in the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), a group of the most important bacteria involved in infections and characterized by multidrug resistance [1].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 466
Diep, B. A., Sensabaugh, G. F., Somboona, N. S., Carleton, H. A., & Perdreau-Remington, F. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2080-2084.2004 · Cited by 257
Livestock-associated Staphylococcus aureus
Fluit, A. C. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03846.x · Cited by 251
Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen
Gao, W., Howden, B. P., & Stinear, T. P. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.030 · Cited by 251
Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae
Band, V. I., Crispell, E. K., Napier, B. A., Herrera, C. M., Tharp, G. K., Vavikolanu, K., Pohl, J., Read, T. D., Bosinger, S. E., Trent, M. S., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.53 · Cited by 248
Incidence of Class 1 Integrons in a Quaternary Ammonium Compound-Polluted Environment
Gaze, W. H., Abdouslam, N., Hawkey, P. M., & Wellington, E. M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1802-1807.2005 · Cited by 245
Management of meningitis due to antibiotic-resistant Acinetobacter species
Kim, B.-N., Peleg, A. Y., Lodise, T. P., Lipman, J., Li, J., Nation, R., & Paterson, D. L. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70055-6 · Cited by 244
Self-citationCui, L., Iwamoto, A., Lian, J.-Q., Neoh, H.-M., Maruyama, T., Horikawa, Y., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.428-438.2006 · Cited by 240
Clavulanic Acid, a Novel Inhibitor of β-Lactamases
Neu, H. C., & Fu, K. P. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.5.650 · Cited by 239
Hsieh, P., Lin, T., Lee, C., Tsai, S., & Wang, J. (2008) · The Journal of Infectious Diseases · doi:10.1086/588383 · Cited by 239
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., Zhu, W., Musser, K. A., Thompson, J., Kohlerschmidt, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-06 · Cited by 237
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
Omadacycline for Community-Acquired Bacterial Pneumonia
Stets, R., Popescu, M., Gonong, J. R., Mitha, I., Nseir, W., Madej, A., Kirsch, C., Das, A. F., Garrity-Ryan, L., Steenbergen, J. N., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1800201 · Cited by 235
Antibiotic Resistance Patterns of Outpatient Pediatric Urinary Tract Infections
Edlin, R. S., Shapiro, D. J., Hersh, A. L., & Copp, H. L. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.069 · Cited by 233
Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide
Vaara, M., & Vaara, T. (1983) · Nature · doi:10.1038/303526a0 · Cited by 232
IS 26 -Mediated Formation of Transposons Carrying Antibiotic Resistance Genes
Harmer, C. J., & Hall, R. M. (2016) · mSphere · doi:10.1128/msphere.00038-16 · Cited by 231
IS Ecp1B -Mediated Transposition of bla CTX-M in Escherichia coli
Poirel, L., Lartigue, M.-F., Decousser, J.-W., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.447-450.2005 · Cited by 229
Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci
Miller, W. R., Bayer, A. S., & Arias, C. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026997 · Cited by 227
Mendes, R. E., Deshpande, L. M., Castanheira, M., DiPersio, J., Saubolle, M. A., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-08 · Cited by 226
Solomkin, J. S., Gardovskis, J., Lawrence, K., Montravers, P., Sway, A., Evans, D., & Tsai, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1029 · Cited by 222
Co-resistance: an opportunity for the bacteria and resistance genes
Cantón, R., & Ruiz-Garbajosa, P. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.07.007 · Cited by 220
Analysis of the clinical antibacterial and antituberculosis pipeline
Theuretzbacher, U., Gottwalt, S., Beyer, P., Butler, M., Czaplewski, L., Lienhardt, C., Moja, L., Paul, M., Paulin, S., Rex, J. H., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30513-9 · Cited by 220
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia
Chuang, Y.-Y., & Huang, Y.-C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70136-1 · Cited by 219
Giddins, M. J., Macesic, N., Annavajhala, M. K., Stump, S., Khan, S., McConville, T. H., Mehta, M., Gomez-Simmonds, A., & Uhlemann, A.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-17 · Cited by 219
Once-Daily Plazomicin for Complicated Urinary Tract Infections
Wagenlehner, F. M. E., Cloutier, D. J., Komirenko, A. S., Cebrik, D. S., Krause, K. M., Keepers, T. R., Connolly, L. E., Miller, L. G., Friedland, I., & Dwyer, J. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1801467 · Cited by 218
Wright, M. S., Suzuki, Y., Jones, M. B., Marshall, S. H., Rudin, S. D., van Duin, D., Kaye, K., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04037-14 · Cited by 216
The hidden life of integrative and conjugative elements
Delavat, F., Miyazaki, R., Carraro, N., Pradervand, N., & van der Meer, J. R. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux008 · Cited by 215
Hill, D., Rose, B., Pajkos, A., Robinson, M., Bye, P., Bell, S., Elkins, M., Thompson, B., MacLeod, C., Aaron, S. D., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5085-5090.2005 · Cited by 213
Prematunge, C., MacDougall, C., Johnstone, J., Adomako, K., Lam, F., Robertson, J., & Garber, G. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2015.228 · Cited by 212
Global emergence of the widespread Pseudomonas aeruginosa ST235 clone
Treepong, P., Kos, V. N., Guyeux, C., Blanc, D. S., Bertrand, X., Valot, B., & Hocquet, D. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.018 · Cited by 212
Weingarten, R. A., Johnson, R. C., Conlan, S., Ramsburg, A. M., Dekker, J. P., Lau, A. F., Khil, P., Odom, R. T., Deming, C., Park, M., et al. (2018) · mBio · doi:10.1128/mbio.02011-17 · Cited by 212
Pinholt, M., Østergaard, C., Arpi, M., Bruun, N. E., Schønheyder, H. C., Gradel, K. O., Søgaard, M., & Knudsen, J. D. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12236 · Cited by 209
Carias, L. L., Rudin, S. D., Donskey, C. J., & Rice, L. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4426-4434.1998 · Cited by 208
Yayan, J., Ghebremedhin, B., & Rasche, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139836 · Cited by 204
Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus
Becker, K., van Alen, S., Idelevich, E. A., Schleimer, N., Seggewiß, J., Mellmann, A., Kaspar, U., & Peters, G. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2402.171074 · Cited by 200
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
Zhang, P., Shi, Q., Hu, H., Hong, B., Wu, X., Du, X., Akova, M., & Yu, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.08.020 · Cited by 200
Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307
Wyres, K. L., Hawkey, J., Hetland, M. A. K., Fostervold, A., Wick, R. R., Judd, L. M., Hamidian, M., Howden, B. P., Löhr, I. H., & Holt, K. E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky492 · Cited by 194
Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future
Lee, T., Pang, S., Abraham, S., & Coombs, G. W. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.08.016 · Cited by 190
Gilbert, M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051565 · Cited by 187
Is Staphylococcus aureus an intracellular pathogen?
Lowy, F. D. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01803-5 · Cited by 186
Emergence of NDM-1 Metallo-β-Lactamase in Pseudomonas aeruginosa Clinical Isolates from Serbia
Jovcic, B., Lepsanovic, Z., Suljagic, V., Rackov, G., Begovic, J., Topisirovic, L., & Kojic, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-11 · Cited by 184
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Rossi, F., Diaz, L., Wollam, A., Panesso, D., Zhou, Y., Rincon, S., Narechania, A., Xing, G., Di Gioia, T. S. R., Doi, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303359 · Cited by 182
Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins
Bauernfeind, A., Schweighart, S., & Chong, Y. (1989) · Infection · doi:10.1007/bf01650718 · Cited by 182
Hassan, K. A., Liu, Q., Henderson, P. J. F., & Paulsen, I. T. (2015) · mBio · doi:10.1128/mbio.01982-14 · Cited by 181
Lehman, S. M., Mearns, G., Rankin, D., Cole, R. L., Smrekar, F., Branston, S. D., & Morales, S. (2019) · Viruses · doi:10.3390/v11010088 · Cited by 179
Transcriptomic and biochemical analyses identify a family of chlorhexidine efflux proteins
Hassan, K. A., Jackson, S. M., Penesyan, A., Patching, S. G., Tetu, S. G., Eijkelkamp, B. A., Brown, M. H., Henderson, P. J. F., & Paulsen, I. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317052110 · Cited by 178
Post, V., White, P. A., & Hall, R. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq095 · Cited by 178
Brolund, A., Lagerqvist, N., Byfors, S., Struelens, M. J., Monnet, D. L., Albiger, B., Kohlenberg, A., & European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) capacity survey group (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.9.1900123 · Cited by 175
DiGiandomenico, A., Warrener, P., Hamilton, M., Guillard, S., Ravn, P., Minter, R., Camara, M. M., Venkatraman, V., MacGill, R. S., Lin, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120033 · Cited by 174
Cano, V., March, C., Insua, J. L., Aguiló, N., Llobet, E., Moranta, D., Regueiro, V., Brennan, G. P., Millán-Lou, M. I., Martín, C., et al. (2015) · Cellular Microbiology · doi:10.1111/cmi.12466 · Cited by 172
Newman, J. W., Floyd, R. V., & Fothergill, J. L. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx124 · Cited by 172
Secor, P. R., Michaels, L. A., Ratjen, A., Jennings, L. K., & Singh, P. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806005115 · Cited by 171
The Tn 3 -family of Replicative Transposons
Nicolas, É., Lambin, M., Dandoy, D., Galloy, C., Nguyen, N., Oger, C. A., & Hallet, B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0060-2014 · Cited by 169
Deshpande, L. M., Jones, R. N., Fritsche, T. R., & Sader, H. S. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.223 · Cited by 169
Giammanco, A., Calà, C., Fasciana, T., & Dowzicky, M. J. (2017) · mSphere · doi:10.1128/msphere.00310-16 · Cited by 169
Sequence of the 50-kb Conjugative Multiresistance Plasmid pRE25 from Enterococcus faecalis RE25
Schwarz, F. V., Perreten, V., & Teuber, M. (2001) · Plasmid · doi:10.1006/plas.2001.1544 · Cited by 166
Lund-Palau, H., Turnbull, A. R., Bush, A., Bardin, E., Cameron, L., Soren, O., Wierre-Gore, N., Alton, E. W. F. W., Bundy, J. G., Connett, G., et al. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1177460 · Cited by 165
Ibrahim, M. E. (2019) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-018-0301-x · Cited by 164
Transferable Mechanisms of Quinolone Resistance from 1998 Onward
Ruiz, J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-19 · Cited by 164
Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
Lob, S. H., Hoban, D. J., Sahm, D. F., & Badal, R. E. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.01.015 · Cited by 163
Replication and conjugative mobilization of broad host-range IncQ plasmids
Meyer, R. (2009) · Plasmid · doi:10.1016/j.plasmid.2009.05.001 · Cited by 163
Community-associated Methicillin-resistantStaphylococcus aureus, Canada
Mulvey, M. R., MacDougall, L., Cholin, B., Horsman, G. B., Fidyk, M., Woods, S., & the Saskatchewan CA-MRSA Study Group (2005) · Emerging infectious diseases · doi:10.3201/eid1106.041146 · Cited by 163
Kidd, T. J., Mills, G., Sá‐Pessoa, J., Dumigan, A., Frank, C. G., Insua, J. L., Ingram, R., Hobley, L., & Bengoechea, J. A. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607336 · Cited by 163
Self-citationEvolution of extended-spectrum β-lactamases by mutation
Gniadkowski, M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01854.x · Cited by 162
Bassetti, M., Castaldo, N., Cattelan, A., Mussini, C., Righi, E., Tascini, C., Menichetti, F., Mastroianni, C. M., Tumbarello, M., Grossi, P., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.001 · Cited by 162
DiazGranados, C. A., & Jernigan, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427512 · Cited by 160
Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008–2014
Peirano, G., Matsumura, Y., Adams, M. D., Bradford, P., Motyl, M., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2406.171648 · Cited by 159
Paul, M., Bishara, J., Yahav, D., Goldberg, E., Neuberger, A., Ghanem‐Zoubi, N., Dickstein, Y., Nseir, W., Dan, M., & Leibovici, L. (2015) · BMJ · doi:10.1136/bmj.h2219 · Cited by 158
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
Zowawi, H. M., Forde, B. M., Alfaresi, M. S., Alzarouni, A., Farahat, Y., Chong, T. M., Yin, W., Chan, K., Li, J., Schembri, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep15082 · Cited by 158
Self-citationNovel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy
Wong, D. W., & van Duin, D. (2017) · Drugs · doi:10.1007/s40265-017-0725-1 · Cited by 158
Katayama, Y., Takeuchi, F., Ito, T., Xue, X., Mizutani-Ui, Y., Kobayashi, I., & Hiramatsu, K. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.9.2711-2722.2003 · Cited by 157
Murphy, E., Huwyler, L., & Bastos, M. D. C. D. F. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04089.x · Cited by 156
Murepavadin: a new antibiotic class in the pipeline
Martín‐Loeches, I., Dale, G. E., & Torres, A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1441024 · Cited by 156
Kos, V. N., Desjardins, C. A., Griggs, A. D., Cerqueira, G., van Tonder, A. J., Holden, M. T. G., Godfrey, P. A., Palmer, K. L., Bodi, K. L., Mongodin, E. F., et al. (2012) · mBio · doi:10.1128/mbio.00112-12 · Cited by 155
Maâtallah, M., Cheriaa, J., Backhrouf, A., Iversen, A., Grundmann, H., Do, T., Lanotte, P., Mastouri, M., Elghmati, M. S., Rojo, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025617 · Cited by 154
Quintiliani, R., & Courvalin, P. M. (1996) · Gene · doi:10.1016/0378-1119(96)00110-2 · Cited by 153
Littlejohn, T. G., DiBerardino, D., Messerotti, L. J., Spiers, S. J., & Skurray, R. A. (1991) · Gene · doi:10.1016/0378-1119(91)90224-y · Cited by 153
In34, a Complex In5 Family Class 1 Integron Containing orf513 and dfrA10
Partridge, S. R., & Hall, R. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.342-349.2003 · Cited by 153
Liu, Y., Wang, H., Du, N., Shen, E.-H., Chen, H., Niu, J., Ye, H., & Chen, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00804-08 · Cited by 153
Genomic Diversity within the Enterobacter cloacae Complex
Paauw, A., Caspers, M. P. M., Schuren, F. H. J., Hall, M. A. L., Delétoile, A., Montijn, R. C., Verhoef, J., & Fluit, A. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003018 · Cited by 151
The epidemiology of carbapenemases in Latin America and the Caribbean
Escandón-Vargas, K., Reyes, S., Gutiérrez, S., & Villegas, M. V. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268918 · Cited by 151
Corbett, D. F., Wise, A., Langley, T., Skinner, K., Trimby, E., Birchall, S., Dorali, A., Sandiford, S. K., Williams, J., Warn, P. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00200-17 · Cited by 148
LaFayette, S. L., Houle, D., Beaudoin, T., Wojewodka, G., Radzioch, D., Hoffman, L. R., Burns, J. L., Dandekar, A. A., Smalley, N. E., Chandler, J. R., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500199 · Cited by 147
First Report of the Multidrug Resistance Gene cfr in Enterococcus faecalis of Animal Origin
Liu, Y., Wang, Y., Wu, C., Shen, Z., Schwarz, Š., Du, X., Dai, L., Zhang, W., Zhang, Q., & Shen, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06091-11 · Cited by 145
Seasonal Variation of Acinetobacter Infections: 1987-1996
McDonald, L. C., Banerjee, S. N., Jarvis, W. R., & System, N. N. I. S. (1999) · Clinical Infectious Diseases · doi:10.1086/313441 · Cited by 145
Marques, C., Belas, A., Franco, A., Aboim, C., Gama, L. T., & Pomba, C. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx401 · Cited by 145
Novel SCC mec type XIII (9A) identified in an ST152 methicillin-resistant Staphylococcus aureus
Baig, S., Johannesen, T. B., Overballe‐Petersen, S., Larsen, J., Larsen, A. R., & Stegger, M. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.03.013 · Cited by 145
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes
Cox, G., Ejim, L. J., Stogios, P. J., Koteva, K. K., Bordeleau, E., Evdokimova, E., Sieron, A. O., Savchenko, A. V., Serio, A. W., Krause, K. M., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00001 · Cited by 145
Shorr, A. F., Lodise, T. P., Corey, G. R., Anda, C. S. D., Fang, E., Das, A., & Prokocimer, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03688-14 · Cited by 144
Palchevskiy, V., & Finkel, S. E. (2006) · Journal of Bacteriology · doi:10.1128/jb.01974-05 · Cited by 144
Chiang, H., Perencevich, E. N., Nair, R., Nelson, R. E., Samore, M. H., Khader, K., Chorazy, M. L., Herwaldt, L. A., Blevins, A., Ward, M., et al. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.254 · Cited by 144
Cabot, G., López-Causapé, C., Ocampo-Sosa, A. A., Sommer, L. M., Domínguez, M. Á., Zamorano, L., Juan, C., Tubau, F., Rodríguez, C., Moyá, B., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01720-16 · Cited by 144
Remschmidt, C., Schröder, C., Behnke, M., Gastmeier, P., Geffers, C., & Kramer, T. S. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0353-x · Cited by 144
Hu, H., Hu, Y., Pan, Y., Liang, H., Wang, H., Wang, X., Hao, Q., Yang, X., Yang, X., Xiao, X., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06199-11 · Cited by 143
Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides
Archer, G. L., & Johnston, J. L. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.1.70 · Cited by 142
Cheng, N., Yu, Y., Tai, H., Hsueh, P., Chang, S., Lai, S. T., Yi, W., & Fang, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis565 · Cited by 142
Dramatic increase in vancomycin-resistant enterococci in Germany
Gastmeier, P., Schröder, C., Behnke, M., Meyer, E., & Geffers, C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku035 · Cited by 140
Gillings, M. R., Xuejun, D., Hardwick, S. A., Holley, M. P., & Stokes, H. W. (2008) · The ISME Journal · doi:10.1038/ismej.2008.98 · Cited by 139
Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Foucault, M.-L., Courvalin, P. M., & Grillot‐Courvalin, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01702-08 · Cited by 137
Schmitz, F., Jones, M. E., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Fluit, A. C., Verhoef, J., Hadding, U., Heinz, H., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1249 · Cited by 137
Zhu, W., Murray, P. R., Huskins, W. C., Jernigan, J. A., McDonald, L. C., Clark, N. C., Anderson, K. F., McDougal, L. K., Hageman, J., Olsen-Rasmussen, M. A., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-10 · Cited by 132
Hasdemir, U. O., Chevalier, J., Nordmann, P., & Pagès, J.-M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2701-2706.2004 · Cited by 131
Characterization of a conjugative staphylococcal mupirocin resistance plasmid
Morton, T. M., Johnston, J. L., PATTERSON, J. E., & Archer, G. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1272 · Cited by 129
An SHV-Derived Extended-Spectrum β-Lactamase in Pseudomonas aeruginosa
Naas, T., Philippon, L., Poirel, L., Ronco, E., & Nordmann, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1281 · Cited by 129
The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
Howden, B. P., Peleg, A. Y., & Stinear, T. P. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.03.047 · Cited by 128
Differential Expression of the Escherichia coli Autoaggregation Factor Antigen 43
Schembri, M. A., Hjerrild, L., Gjermansen, M., & Klemm, P. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2236-2242.2003 · Cited by 126
Self-citationStudies of the repressor (BlaI) of β‐lactamase synthesis in Staphylococcus aureus
Gregory, P. D., Lewis, R. A., Curnock, S. P., & Dyke, K. G. H. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4051770.x · Cited by 126
tcaA Inactivation Increases Glycopeptide Resistance in Staphylococcus aureus
Maki, H., Holmes, N., Bischoff, M., Wada, A., & Berger‐Bächi, B. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.1953-1959.2004 · Cited by 126
Pu, W., Yang, S., Li, J., Li, C., Yang, Z., Deng, H., & ChunXia, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088134 · Cited by 125
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
Hauck, C. G., Cober, E., Richter, S. S., Pérez, F., Salata, R. A., Kalayjian, R. C., Watkins, R., Scalera, N. M., Doi, Y., Kaye, K. S., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.023 · Cited by 125
Bauernfeind, A., Schneider, I., Jungwirth, R., Sahly, H., & Ullmann, U. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1924 · Cited by 124
Gomez‐Simmonds, A., Annavajhala, M. K., Wang, Z., Maćešić, N., Hu, Y., Giddins, M. J., O’Malley, A., Toussaint, N. C., Whittier, S., Torres, V. J., et al. (2018) · mBio · doi:10.1128/mbio.00542-18 · Cited by 124
Ali, S. O., Yu, X. Q., Robbie, G. J., Wu, Y., Shoemaker, K., Yu, L., DiGiandomenico, A., Keller, A. E., Anude, C., Hernandez-Illas, M., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.004 · Cited by 124
Jumping the Barrier to β-Lactam Resistance in Staphylococcus aureus
Katayama, Y., Zhang, H.-Z., Hong, D. H., & Chambers, H. F. “. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.18.5465-5472.2003 · Cited by 123
Schweizer, H. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.394 · Cited by 123
An Experimental Framework for Quantifying Bacterial Tolerance
Brauner, A., Shoresh, N., Fridman, O., & Balaban, N. Q. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.05.014 · Cited by 122
HIF-1 : a master regulator of innate host defenses?
Zarember, K. A., & Malech, H. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25740 · Cited by 120
Quan, J., Zhao, D., Liu, L., Chen, Y., Zhou, J., Jiang, Y., Du, X., Zhou, Z., Akova, M., & Yu, Y. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw372 · Cited by 120
Zhao, C., Liu, Y., Zhao, M., Liu, Y., Yu, Y., Chen, H., Sun, Q., Chen, H., Jiang, W., Liu, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038577 · Cited by 119
Ewers, C., Stamm, I., Pfeifer, Y., Wieler, L. H., Kopp, P. A., Schønning, K., Prenger‐Berninghoff, E., Scheufen, S., Stolle, I., Guenther, S., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku217 · Cited by 119
Vaara, M., Siikanen, O., Apajalahti, J., Fox, J., Møller, J. K., He, H., Poudyal, A., Li, J., Nation, R. L., & Vaara, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01439-09 · Cited by 119
Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii
Leus, I. V., Weeks, J. W., Bonifay, V., Smith, L., Richardson, S., & Zgurskaya, H. I. (2018) · Journal of Bacteriology · doi:10.1128/jb.00049-18 · Cited by 119
Mantri, Y. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkh059 · Cited by 117
First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
Melo‐Cristino, J., Resina, C., Manuel, V., Lito, L., & Ramirez, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61219-2 · Cited by 116
IRT and CMT β-lactamases and inhibitor resistance
Cantón, R., Morosini, M.-I., Martin, O., de la Maza, S., & de la Pedrosa, E. G. G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01849.x · Cited by 115
Okumura, C. Y. M., Hollands, A., Tran, D. N., Olson, J., Dahesh, S., von Köckritz-Blickwede, M., Thienphrapa, W., Corle, C., Jeung, S. N., Kotsakis, A., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0882-3 · Cited by 115
Jain, R., Beckett, V. V., Konstan, M. W., Accurso, F. J., Burns, J. L., Mayer-Hamblett, N., Milla, C. E., VanDevanter, D. R., & Chmiel, J. F. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.12.006 · Cited by 115
Antibiotic Resistance Acquired through a DNA Damage-Inducible Response in Acinetobacter baumannii
Norton, M., Spilkia, A. J., & Godoy, V. G. (2013) · Journal of Bacteriology · doi:10.1128/jb.02176-12 · Cited by 114
Launay, A., Ballard, S. A., Johnson, P. D. R., Grayson, M. L., & Lambert, T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1054-1062.2006 · Cited by 113
Tanaseanu, C. M., Bergallo, C., Teglia, O., Jasovich, A., Oliva, M. E., Dukart, G., Dartois, N., Cooper, C. A., Gandjini, H., & Mallick, R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.009 · Cited by 112
Shearer, J. E. S., Wireman, J., Hostetler, J. B., Forberger, H., Borman, J., Gill, J. E., Sánchez, S., Mankin, A. S., LaMarre, J. M., Lindsay, J. A., et al. (2011) · G3 Genes Genomes Genetics · doi:10.1534/g3.111.000760 · Cited by 111
Alexander, E. L., Goldberg, L., Das, A., et al. (2019) · JAMA · doi:10.1001/jama.2019.15468 · Cited by 111
Milla, C. E., Chmiel, J. F., Accurso, F. J., VanDevanter, D. R., Konstan, M. W., Yarranton, G. T., Geller, D. E., & for the KB001 Study Group (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22890 · Cited by 109
Kobayashi, N., Alam, M. M., Nishimoto, Y., Urasawa, S., Uehara, N., & Watanabe, N. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005271 · Cited by 108
Klebsiella pneumoniae ST307 with bla OXA-181, South Africa, 2014–2016
Lowe, M., Kock, M. M., Coetzee, J., Hoosien, E., Peirano, G., Strydom, K., Ehlers, M. M., Mbelle, N. M., Shashkina, E., Haslam, D. B., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181482 · Cited by 108
Pinholt, M., Larner-Svensson, H., Littauer, P., Moser, C. E., Pedersen, M., Lemming, L. E., Ejlertsen, T., Søndergaard, T. S., Holzknecht, B. J., Justesen, U. S., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv142 · Cited by 107
Papp‐Wallace, K. M., Barnes, M. D., Alsop, J., Taracila, M. A., Bethel, C. R., Becka, S. A., van Duin, D., Kreiswirth, B. N., Kaye, K. S., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-18 · Cited by 107
Sidhu, M. S., Heir, E., Sørum, H. R., & Holck, A. L. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152773374 · Cited by 104
Sligl, W., Dragan, T., & Smith, S. W. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.06.024 · Cited by 102
Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone
Bosi, C., Davin‐Regli, A., Bornet, C., Malléa, M., Pagès, J., & Claude Bollet, C. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2165-2169.1999 · Cited by 101
Zhang, S., Sun, X., Chang, W., Dai, Y., & Ma, X. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136082 · Cited by 99
Plazomicin: A Next‐Generation Aminoglycoside
Shaeer, K. M., Zmarlicka, M. T., Chahine, E. B., et al. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2203 · Cited by 99
Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
Younis, W., Thangamani, S., & Seleem, M. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150506154434 · Cited by 99
Petty, L. A., Henig, O., Patel, T. S., Pogue, J. M., & Kaye, K. S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s150447 · Cited by 98
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
Göttig, S., Frank, D., Mungo, E., Nolte, A., Hogardt, M., Besier, S. M., & Wichelhaus, T. A. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz330 · Cited by 98
Cameron, A. D. S., & Redfield, R. J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl734 · Cited by 93
Genomic epidemiology of global VIM-producing Enterobacteriaceae
Matsumura, Y., Peirano, G., DeVinney, R., Bradford, P. A., Motyl, M. R., Adams, M. D., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx148 · Cited by 93
Morton, T. M., Eaton, D., Johnston, J. L., & Archer, G. L. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.14.4436-4447.1993 · Cited by 92
A Semi‐Synthetic Glycoconjugate Vaccine Candidate for Carbapenem‐Resistant Klebsiella pneumoniae
Seeberger, P. H., Pereira, C. L., Khan, N., Xiao, G., Diago‐Navarro, E., Reppe, K., Opitz, B., Fries, B. C., & Witzenrath, M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201700964 · Cited by 90
Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis
Langan, K. M., Kotsimbos, T. C., & Peleg, A. Y. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000217 · Cited by 89
Molecular Epidemiology of Enterococcal Bacteremia in Australia
Coombs, G. W., Pearson, J. C., Daley, D. A., Le, T., Robinson, J. O., Gottlieb, T., Howden, B. P., Johnson, P. D. R., Bennett, C. M., Stinear, T. P., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03286-13 · Cited by 89
Lim, S., Tanimoto, K., Tomita, H., & Ike, Y. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.00749-06 · Cited by 89
Dai, Y., Liu, J., Guo, W., Meng, H., Huang, Q., He, L., Gao, Q., Lv, H., Liu, Y., Wang, Y., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1595161 · Cited by 89
Antimicrobial resistance in nephrology
Wang, T. Z., Kodiyanplakkal, R. P., & Calfee, D. P. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0150-7 · Cited by 89
Carlet, J. M., Astagneau, P., Brun‐Buisson, C., Coignard, B., Salomon, V., Tran, B., Desenclos, J. C., Jarlier, V., Schlemmer, B., Parneix, P., et al. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/598682 · Cited by 88
Bender, J. K., Strommenger, B., Steglich, M., Zimmermann, O., Fenner, I., Lensing, C., Dagwadordsch, U., Kekulé, A. S., Werner, G., & Layer, F. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv025 · Cited by 88
Trends in 393 necrotizing acute soft tissue infection patients 2000–2008
Bernal, N. P., Latenser, B. A., Born, J. M., & Liao, J. (2011) · Burns · doi:10.1016/j.burns.2011.07.008 · Cited by 88
Validation of a Novel Murine Wound Model of Acinetobacter baumannii Infection
Thompson, M. G., Black, C. C., Pavlicek, R. L., Honnold, C. L., Wise, M. C., Alamneh, Y. A., Moon, J. K., Kessler, J. L., Si, Y., Williams, R. H., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01944-13 · Cited by 87
Tigecycline: a critical safety review
Kaewpoowat, Q., & Ostrosky-Zeichner, L. L. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.997206 · Cited by 87
Thiolas, A., Bollet, C., Scola, B. L., Raoult, D., & Pagès, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1354-1358.2005 · Cited by 87
Tsai, C. W., & Morris, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01320 · Cited by 87
Intraspecies Transfer of the Chromosomal Acinetobacter baumannii bla NDM-1 Carbapenemase Gene
Krahn, T., Wibberg, D., Maus, I., Winkler, A., Bontron, S., Sczyrba, A., Nordmann, P., Pühler, A., Poirel, L., & Schlüter, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00124-16 · Cited by 87
Xiong, J., Alexander, D. C., Ma, J. H., Déraspe, M., Low, D. E., Jamieson, F., & Roy, P. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-13 · Cited by 86
Zou, J., & Shankar, N. (2015) · Cellular Microbiology · doi:10.1111/cmi.12556 · Cited by 85
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Rello, J., Krenn, C.-G., Locker, G. J., Pilger, E., Madl, C., Balica, L., Dugernier, T., Laterre, P., Spapen, H. D., Depuydt, P. O., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1601-9 · Cited by 85
Cryo-Electron Microscopy Structure of an Acinetobacter baumannii Multidrug Efflux Pump
Su, C., Morgan, C. E., Kambakam, S., Rajavel, M., Scott, H., Huang, W., Emerson, C. C., Taylor, D. J., Stewart, P. L., Bonomo, R. A., et al. (2019) · mBio · doi:10.1128/mbio.01295-19 · Cited by 85
Zinkernagel, A. S., Peyssonnaux, C., Johnson, R. S., & Nizet, V. (2008) · The Journal of Infectious Diseases · doi:10.1086/524843 · Cited by 83
Locke, J. B., Morales, G., Hilgers, M. T., Kedar, G. C., Rahawi, S., Picazo, J. J., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-10 · Cited by 83
Where are we with monoclonal antibodies for multidrug-resistant infections?
McConnell, M. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.002 · Cited by 83
Harris, P. N. A., Peleg, A. Y., Iredell, J. R., Ingram, P. R., Miyakis, S., Stewardson, A. J., Rogers, B. A., McBryde, E. S., Roberts, J. A., Lipman, J., et al. (2015) · Trials · doi:10.1186/s13063-014-0541-9 · Cited by 82
Self-citationChemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance
Bohlmann, L., Oliveira, D. M. P. D., El-Deeb, I. M., Brazel, E. B., Harbison-Price, N., Ong, C. Y., Rivera-Hernández, T., Ferguson, S. A., Cork, A. J., Phan, M., et al. (2018) · mBio · doi:10.1128/mbio.02391-18 · Cited by 82
Self-citationHamidian, M., Nigro, S. J., & Hall, R. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks318 · Cited by 81
Berger, E. A., McClellan, S. A., Vistisen, K. S., & Hazlett, L. D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003457 · Cited by 81
The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England
Duerden, B. I., Fry, C., Johnson, A. P., & Wilcox, M. H. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv035 · Cited by 81
Liu, W. J., Fu, L., Huang, M., Zhang, J. P., Wu, Y., Zhou, Y., Zeng, J., & Wang, G. X. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000403 · Cited by 81
Wang, Y., Tong, M.-K., Chow, K., Cheng, V. C., Tse, C. W., Wu, A. K. L., Lai, R. W., Luk, W., Tsang, D. N., & Ho, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02272 · Cited by 81
Kussmann, M., Karer, M., Obermüller, M., Schmidt, K., Barousch, W., Moser, D., Nehr, M., Ramharter, M., Poeppl, W., Makristathis, A., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0205-z · Cited by 81
Hamidian, M., Holt, K. E., Pickard, D., Dougan, G., & Hall, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt454 · Cited by 80
Cochetti, I., Tili, E., Mingoia, M., Varaldo, P. E., & Montanari, M. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01457-07 · Cited by 79
Goering, R. V., & Ruff, E. A. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.3.450 · Cited by 79
Masi, M., Winterhalter, M., & Pagès, J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-18768-2_4 · Cited by 77
Zhu, W., Clark, N. C., & Patel, J. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01587-12 · Cited by 76
Towner, K. J., Evans, B. A., Villa, L., Levi, K., Hamouda, A., Amyes, S. G. B., & Carattoli, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01661-10 · Cited by 75
Sahibzada, S., Abraham, S., Coombs, G. W., Pang, S., Hernández‐Jover, M., Jordan, D., & Heller, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04789-0 · Cited by 74
A 16-Year Prospective Study of Community-Onset Bacteremic Acinetobacter Pneumonia
Davis, J. S., McMillan, M., Swaminathan, A. D., Kelly, J. A., Piera, K., Baird, R., Currie, B. J., & Anstey, N. M. (2014) · CHEST Journal · doi:10.1378/chest.13-3065 · Cited by 72
mecA -Positive Staphylococcus aureus with Low-Level Oxacillin MIC in Taiwan
Chen, F.-J., Huang, I., Wang, C.-H., Chen, P., Wang, H.-Y., Lai, J., Shiau, Y., & Lauderdale, T.-L. Y. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06711-11 · Cited by 71
Malek, A., McGlynn, K. A., Taffner, S. M., Fine, L., Tesini, B. L., Wang, J., Mostafa, H. H., Petry, S., Perkins, A. S., GRAMAN, P. S., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02577-18 · Cited by 71
Ceftobiprole: drug evaluation and place in therapy
Giacobbe, D. R., Rosa, F. G. D., Bono, V. D., Grossi, P., Pea, F., Petrosillo, N., Rossolini, G. M., Tascini, C., Tumbarello, M., Viale, P., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1667229 · Cited by 70
Erlandson, K. M., Sun, J., Iwen, P. C., & Rupp, M. E. (2007) · Clinical Infectious Diseases · doi:10.1086/523588 · Cited by 69
Liu, J., Yang, L., Chen, D., Peters, B. M., Li, L., Li, B. J., Xu, Z., & Shirtliff, M. E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.09.008 · Cited by 69
Direct involvement of IS26 in an antibiotic resistance operon
Lee, K. Y., Hopkins, J. D., & Syvanen, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.6.3229-3236.1990 · Cited by 68
In the centre of an epidemic: Fifteen years of LA-MRSA CC398 at the University Hospital Münster
van Alen, S., Ballhausen, B., Peters, G., et al. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.01.021 · Cited by 68
Small, Enigmatic Plasmids of the Nosocomial Pathogen, Acinetobacter baumannii: Good, Bad, Who Knows?
Lean, S. S., & Yeo, C. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01547 · Cited by 68
Outbreaks in Health Care Settings
Sood, G., & Perl, T. M. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.04.003 · Cited by 67
Lim, W. W., Wu, P., Bond, H. S., Wong, J. Y., Ni, K., Seto, W., Jit, M., & Cowling, B. J. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.08.014 · Cited by 66
"Celbenin"-resistant Staphylococci
Stewart, G. T. (1960) · BMJ · doi:10.1136/bmj.2.5205.1085-a · Cited by 65
Krapp, F., Morris, A. R., Ozer, E. A., & Hauser, A. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-13524-8 · Cited by 65
Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens
Bonomo, R. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz823 · Cited by 65
Libisch, B., Poirel, L., Lepšanović, Z., Mirović, V., Balogh, B., Pászti, J., Hunyadi, Z., Dobák, A., Füzi, M., & Nordmann, P. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00483.x · Cited by 63
Chevalier, J., Mulfinger, C., Garnotel, É., Nicolas, P., Davin‐Regli, A., & Pagès, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003203 · Cited by 62
Creech, C. B., Frenck, R. W., Sheldon, E. A., Seiden, D., Kankam, M. K., Zito, E. T., Girgenti, D., Severs, J. M., Immermann, F. W., McNeil, L. K., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.032 · Cited by 62
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Identification of antimicrobial peptides from the human gut microbiome using deep learning
Ma, Y., Guo, Z., Xia, B., Zhang, Y., Liu, X., Yu, Y., Tang, N., Tong, X., Wang, M., Ye, X., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01226-0 · Cited by 490
A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides
Browne, K., Chakraborty, S., Chen, R., Willcox, M. D., Black, D. S., Walsh, W. R., & Kumar, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197047 · Cited by 482
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Metadata
- Authors
- De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-06-17
- Volume
- 33
- Issue
- 3
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3024693033
- Cited by
- 2,078
- References
- 466
- FWCI
- 65.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.